Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000165969 | SCV000216726 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000458692 | SCV000554130 | likely benign | Peutz-Jeghers syndrome | 2023-12-17 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000165969 | SCV001355797 | likely benign | Hereditary cancer-predisposing syndrome | 2019-01-07 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002228755 | SCV002511508 | likely benign | not specified | 2022-04-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003937513 | SCV004756493 | likely benign | STK11-related disorder | 2024-03-01 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
All of Us Research Program, |
RCV000458692 | SCV004816382 | likely benign | Peutz-Jeghers syndrome | 2023-06-26 | criteria provided, single submitter | clinical testing |